BRANDEE BURLEY: Open Payments
NPI 1184037244 · GENEVA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$349 in 17 payments from 11 companies in 2025. Trend: 2023 $1,003 · 2024 $704 · 2025 $349
Food & beverage: $349
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 3 | $62 |
| ABBVIE INC. | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| Janssen Biotech, Inc. | 2 | $43 |
| Ardelyx, Inc. | 1 | $28 |
| Novo Nordisk Inc | 1 | $23 |
| Gilead Sciences, Inc. | 1 | $21 |
| Ipsen Biopharmaceuticals, Inc | 1 | $18 |
| Myriad Genetic Laboratories, Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $16 |
Products named: VOQUEZNA, RINVOQ, ENTYVIO, TREMFYA, IBSRELA, Wegovy, IQIRVO, MYRISK.
Industry payments across NY — which companies pay providers there.
